New 2026 Emily’s Entourage Translational Research Grant to Develop Mucus-Penetrating Gene Editing Delivery for Cystic Fibrosis
Engineered lipid nanoparticles designed to overcome the cystic fibrosis mucus barrier could enable targeted gene editing through inhalation Lower Merion, PA—August 18,... Read More
Emily’s Entourage Funds Synthetic Biology Approach to Enable Durable Gene Therapy for Cystic Fibrosis
Engineered synthetic receptor technology aims to selectively expand corrected airway stem cells and improve long-term treatment durability. Lower Merion, PA—August 13, 2026—Emily’s... Read More
Emily’s Entourage Awards New Funding to University of Texas at Austin to Advance Breakthrough Gene Editing Therapy for Hard-to-Treat Cystic Fibrosis Mutations
With support from Emily’s Entourage, new retron editor technology aims to restore lung function for the 10% of people with cystic fibrosis... Read More
Emily’s Entourage Awards 2025 Translational Research Grant to Develop New, Highly-Targeted Therapy for Cystic Fibrosis Nonsense Mutations
The newly-funded project seeks to develop a highly targeted treatment to bypass cystic fibrosis nonsense mutations, offering new hope for those still... Read More
Emily’s Entourage Awards Translational Research Grant to Accelerate Prime Editing for Hard-to-Treat Cystic Fibrosis Mutations
The newly funded project will harness high-throughput gene editing and computational modeling to develop tailored therapies for people with cystic fibrosis unable... Read More
